Cargando…
Challenges of defining a non-inferiority margin: a case study of non-inferiority randomized controlled trials of oral anti-thrombolytic agents for prophylaxis of venous thromboembolic events after orthopedic surgery
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287747/ http://dx.doi.org/10.1186/1745-6215-12-S1-A32 |
_version_ | 1782224734389272576 |
---|---|
author | Wangge, Grace Klungel, Olaf H Roes, Kit CB de Boer, Antonius Hoes, Arno W Knol, Mirjam J |
author_facet | Wangge, Grace Klungel, Olaf H Roes, Kit CB de Boer, Antonius Hoes, Arno W Knol, Mirjam J |
author_sort | Wangge, Grace |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3287747 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-32877472012-02-28 Challenges of defining a non-inferiority margin: a case study of non-inferiority randomized controlled trials of oral anti-thrombolytic agents for prophylaxis of venous thromboembolic events after orthopedic surgery Wangge, Grace Klungel, Olaf H Roes, Kit CB de Boer, Antonius Hoes, Arno W Knol, Mirjam J Trials Oral Presentation BioMed Central 2011-12-13 /pmc/articles/PMC3287747/ http://dx.doi.org/10.1186/1745-6215-12-S1-A32 Text en Copyright ©2011 Wangge et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Oral Presentation Wangge, Grace Klungel, Olaf H Roes, Kit CB de Boer, Antonius Hoes, Arno W Knol, Mirjam J Challenges of defining a non-inferiority margin: a case study of non-inferiority randomized controlled trials of oral anti-thrombolytic agents for prophylaxis of venous thromboembolic events after orthopedic surgery |
title | Challenges of defining a non-inferiority margin: a case study of non-inferiority randomized controlled trials of oral anti-thrombolytic agents for prophylaxis of venous thromboembolic events after orthopedic surgery |
title_full | Challenges of defining a non-inferiority margin: a case study of non-inferiority randomized controlled trials of oral anti-thrombolytic agents for prophylaxis of venous thromboembolic events after orthopedic surgery |
title_fullStr | Challenges of defining a non-inferiority margin: a case study of non-inferiority randomized controlled trials of oral anti-thrombolytic agents for prophylaxis of venous thromboembolic events after orthopedic surgery |
title_full_unstemmed | Challenges of defining a non-inferiority margin: a case study of non-inferiority randomized controlled trials of oral anti-thrombolytic agents for prophylaxis of venous thromboembolic events after orthopedic surgery |
title_short | Challenges of defining a non-inferiority margin: a case study of non-inferiority randomized controlled trials of oral anti-thrombolytic agents for prophylaxis of venous thromboembolic events after orthopedic surgery |
title_sort | challenges of defining a non-inferiority margin: a case study of non-inferiority randomized controlled trials of oral anti-thrombolytic agents for prophylaxis of venous thromboembolic events after orthopedic surgery |
topic | Oral Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287747/ http://dx.doi.org/10.1186/1745-6215-12-S1-A32 |
work_keys_str_mv | AT wanggegrace challengesofdefininganoninferioritymarginacasestudyofnoninferiorityrandomizedcontrolledtrialsoforalantithrombolyticagentsforprophylaxisofvenousthromboemboliceventsafterorthopedicsurgery AT klungelolafh challengesofdefininganoninferioritymarginacasestudyofnoninferiorityrandomizedcontrolledtrialsoforalantithrombolyticagentsforprophylaxisofvenousthromboemboliceventsafterorthopedicsurgery AT roeskitcb challengesofdefininganoninferioritymarginacasestudyofnoninferiorityrandomizedcontrolledtrialsoforalantithrombolyticagentsforprophylaxisofvenousthromboemboliceventsafterorthopedicsurgery AT deboerantonius challengesofdefininganoninferioritymarginacasestudyofnoninferiorityrandomizedcontrolledtrialsoforalantithrombolyticagentsforprophylaxisofvenousthromboemboliceventsafterorthopedicsurgery AT hoesarnow challengesofdefininganoninferioritymarginacasestudyofnoninferiorityrandomizedcontrolledtrialsoforalantithrombolyticagentsforprophylaxisofvenousthromboemboliceventsafterorthopedicsurgery AT knolmirjamj challengesofdefininganoninferioritymarginacasestudyofnoninferiorityrandomizedcontrolledtrialsoforalantithrombolyticagentsforprophylaxisofvenousthromboemboliceventsafterorthopedicsurgery |